Description

Dectova (Zanamivir IV) – Antiviral for Severe Influenza (Rx)

Dectova contains zanamivir, a neuraminidase inhibitor antiviral used for the treatment of complicated and potentially life-threatening influenza infections in adults and children (from 6 months of age). It is specifically indicated for patients who are hospitalized or when other antiviral options (such as oral or inhaled treatments) are not suitable or ineffective.

buy Dectova without prescription

We sell over-the-counter Dectova medicine; buy medicines with no prescription
livraison rapide, discrète et fiable
Paiement rapide et sécurisé
faire des achats en toute discrétion sans laisser de traces

Zanamivir works by inhibiting the viral neuraminidase enzyme, preventing the release of new influenza virus particles from infected cells. This limits viral spread within the respiratory tract and helps reduce disease severity and progression.

Détails clés

• Active Ingredient: Zanamivir
• Brand Name: Dectova
• Drug Class: Neuraminidase inhibitor (antiviral)
• Indication: Severe or complicated influenza infection
• Route: Intravenous (IV) infusion
• Use Setting: Primarily hospital-based treatment
• Statut de la prescription : Médicament délivré sur ordonnance

Cahier des charges

• Dosage Form: Powder for concentrate for solution for infusion
• Administration: Intravenous infusion (after reconstitution and dilution)
• Dosing Frequency: Typically twice daily (adjusted by weight, age, renal function)
• Onset of Action: Rapid systemic antiviral activity after IV administration
• Half-Life: ~2.5–3 hours
• Metabolism: Minimal metabolism
• Excrétion : Principalement rénale (médicament inchangé)
• Storage: Store vials below 25°C; protect from light

Dosage et administration

• Dose is individualized based on patient weight, age, and renal function
• Common adult dosing: 600 mg IV twice daily (adjusted as needed)
• Treatment duration typically 5–10 days, depending on severity
• Requires clinical monitoring in hospital settings

Compatibilité / Utilisation appropriée

• Patients with severe or complicated influenza
• Individuals unable to take oral or inhaled antivirals
• Hospitalized patients, including those in intensive care
• Suitable for pediatric and adult patients (per guidelines)
• Requires specialist medical supervision

Why Choose Dectova?

Dectova provides a critical IV antiviral option for managing severe influenza infections, especially when standard oral or inhaled therapies are not viable. Its targeted antiviral mechanism and hospital-based administration make it essential in critical care and infectious disease management.